Evidence check: ApoB in the context of Darmgesundheit

ApoB (apolipoprotein B) is a core component of LDL particles and a strong predictor of cardiovascular risk. In the context of gut health, evidence is indirect and mechanistic: the gut microbiome can influence lipid metabolism via short-chain fatty acids, bile acid pathways, and inflammation, potentially affecting ApoB levels. Some studies report associations between specific bacteria (e.g., Akkermansia, Prevotella) and ApoB, but the evidence is weak and insufficient for clinical guidance. ApoB is not a standard gut health marker; it remains a cardiovascular biomarker. MyBody-X may include ApoB in a lipid panel, but interpreting it for gut health would be speculative. Evidence level: mechanistic/unclear. Safety note: ApoB measurement is harmless, but misinterpretation could lead to unnecessary anxiety or supplementation.